Most people were clear or almost clear with just 2 doses (at 12 weeks). That means fewer symptoms like plaques, redness, and flakes. All with dosing every 12 weeks—only 4 doses a year—after 2 initial doses.
Individual results may vary.
START RIGHT WITH ILUMYA™
Studies showed that 6 out of 10 people were clear or almost clear after 2 doses of ILUMYA™ and continued to clear over time.
Individual results may vary.
WHAT TO EXPECT
After your 2 initial doses, ILUMYA™ is given to you every 12 weeks by your dermatologist—just 4 doses a year.
DISCOVER DOSINGILUMYA™ is a biologic medicine. Biologics like ILUMYA™ target a specific part of the immune system and block the molecules that make psoriasis worse.
Learn how ILUMYA™ILUMYA™ is not for everyone. Ask your doctor if ILUMYA™ could be the treatment you’re looking for.
To get the most out of treatment, enroll in ILUMYA SUPPORT Lighting the Way™. Our support team is ready to help you get started.
Make sure to enroll in ILUMYA SUPPORT Lighting the Way™, and see if you’re eligible to receive ILUMYA™ at low or no cost.
Get the benefits
Here's your chance to get help finding your next treatment while also helping other psoriasis patients. By signing up, you receive more information about ILUMYA™ and how it may be the treatment option for you. As a thank you for signing up, Sun Pharma will donate $5 to the National Psoriasis Foundation® (NPF) on your behalf. This donation will help support the NPF's mission to drive efforts to cure psoriatic disease and improve the lives of those affected.
ILUMYA is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy (treatment using ultraviolet or UV light).
What is the most important information I should know about ILUMYA?
Do not use ILUMYA if you have had a severe allergic reaction to ILUMYA or any of its ingredients.
Get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction:
ILUMYA is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with ILUMYA and may treat you for TB before you begin treatment with ILUMYA if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with ILUMYA.
Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
Before receiving ILUMYA, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
It is not known if ILUMYA is safe and effective in children under 18 years of age.
What are the possible side effects of ILUMYA?
ILUMYA may cause serious side effects. See “What is the most important information I should know about ILUMYA?”
The most common side effects of ILUMYA include: upper respiratory infections, injection site reactions and diarrhea. These are not all of the possible side effects of ILUMYA. Call your doctor for medical advice about side effects.
You are encouraged to report any negative side effects of ILUMYA to FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You are also encouraged to report side effects or ADEs (adverse drug events) to our Drug Safety Department at 1-800-406-7984 or drug.safetyUSA@sunpharma.com (preferred) with as much information as available.
Please read the full Prescribing Information and Medication Guide for ILUMYA and discuss any questions with your doctor.
